Two studies reported a significant reduction in lower limb amputations (LLA) and diabetic foot ulcers, while one study found no significant difference in LLA compared to other diabetic therapies
Understanding these variations is essential to maximizing the therapeutic potential of GLP-1 for individuals seeking effective weight management solutions
Research shows that taking a GLP-1 or GIP/GLP-1 may reduce calorie intake by 16 to 39%, leading to weight loss
Fatigue was evaluated by Wessely and Powell scores consisting of physical fatigue, mental fatigue, and fatigue severity [21]
Moshal KS, Tipparaju SM, Vacek TP, Kumar M, Singh M, Frank IE, et al
For people without a weight-related health condition, Pew found that 12% of respondents said GLP-1s are good options, while 62% said these drugs are not good options